Tempus AI Inc
NASDAQ:TEM
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
24.96
77.62
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Tempus AI Inc
Cost of Revenue
Tempus AI Inc
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Tempus AI Inc
NASDAQ:TEM
|
Cost of Revenue
-$245.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cost of Revenue
-$25.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-11%
|
|
|
Danaher Corp
NYSE:DHR
|
Cost of Revenue
-$8.6B
|
CAGR 3-Years
8%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
0%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cost of Revenue
-$1.5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-3%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Cost of Revenue
-$2.9B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-11%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cost of Revenue
-$9.9B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-10%
|
|
Tempus AI Inc
Glance View
Tempus AI Inc. is revolutionizing the landscape of healthcare by leveraging cutting-edge artificial intelligence to enhance patient care and outcomes. Founded in 2015, the company has focused on integrating advanced data analytics and machine learning technologies to curate personalized treatment plans in oncology and beyond. Their innovative platform aggregates clinical and molecular data, allowing healthcare professionals to make informed decisions based on the latest research and patient-specific information. By partnering with leading healthcare institutions, Tempus is transforming the way physicians approach diagnosis and treatment, ultimately driving a more precise and effective healthcare system. For investors, Tempus represents a compelling opportunity in the rapidly growing health tech sector, especially as demands for personalized medicine continue to rise. The company's robust technology, combined with a strong leadership team and strategic partnerships, positions it as a frontrunner in data-driven healthcare solutions. Tempus has already demonstrated significant traction, evidenced by its expanding clientele and investment from prominent venture capital firms. With a commitment to enhancing patient outcomes and reducing healthcare costs, Tempus AI Inc. is not only shaping the future of medicine but also presenting a promising opportunity for those looking to invest in the intersection of technology and health.
See Also
What is Tempus AI Inc's Cost of Revenue?
Cost of Revenue
-245.6m
USD
Based on the financial report for Dec 31, 2023, Tempus AI Inc's Cost of Revenue amounts to -245.6m USD.
What is Tempus AI Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 1Y
-29%
Over the last year, the Cost of Revenue growth was -29%.
You don't have any saved screeners yet
